Form4.ai tracks every SEC insider trade in real time. See every SYRE insider filing with a free account — no card.
See every SYRE insider filing — free account, no card.
Free accountSpyre Therapeutics, Inc. (SYRE) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $7.5M. Most recent filing: Oct. 2, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 2, 2026 SEC filing | King-Jones Heidy See Remarks | Cashless exercise | $2,214,373 | — |
| Oct 2, 2026 SEC filing | Turtle Cameron Chief Executive Officer | Sold | $1,380,105 | — |
| Oct 2, 2026 SEC filing | Burrows Scott L Chief Financial Officer | Vest & sell-to-cover | 0 sh | — |
Create a free account to see all 7 SYRE filings from the last 90 days. No card needed.
Create free accountWant SYRE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.